Clinical Trials Directory

Trials / Unknown

UnknownNCT01480687

Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia

Effects of Fish Oil Supplementation on Vascular Structure and Function in Hypertensive Patients With Hypertriglyceridemia

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
52 (estimated)
Sponsor
Hospital Universitario Pedro Ernesto · Academic / Other
Sex
All
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to compare the effects of ciprofibrate versus omega-3 fatty acid supplementation on the vascular structure and function in hypertensive patients with hypertriglyceridemia.

Detailed description

Hypertensive patients aged 40-65 years, both genders, presenting serum triglycerides levels higher than 150 mg/dl will be randomized into two groups. The first group will be receiving ciprofibrate 100mg/day and the second group will be receiving fish oil 1800mg/day. All patients will be evaluated with brachial flow-mediated dilation and with EndoPAT to assess endothelial function before and after supplementation. SPHYGMOCOR and pulse wave velocity (PWV) measurements will also be obtained.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTDHA-EPA1800 mg/day
DRUGCiprofibrate100 mg/day

Timeline

Start date
2011-05-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2011-11-29
Last updated
2011-11-29

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01480687. Inclusion in this directory is not an endorsement.